Skip to content
Living Systematic Review
COVID 19
Chikungunya
Lassa Fever
Mpox
RSV
Effectiveness and immunogenicity outcome
Safety outcomes
Disease X
Resources
Steering Committee
STAG
Development team
Spotlights
Close Trigger
Living Systematic Review
Living Systematic Review Covid-19
Pairwise Meta Analyses Covid-19
Proportional Meta Analyses
Quality Assessment COVID19
PRISMA Flow Diagram
Resources
Steering Committee
STAG
Development team
Menu
Living Systematic Review
Living Systematic Review Covid-19
Pairwise Meta Analyses Covid-19
Proportional Meta Analyses
Quality Assessment COVID19
PRISMA Flow Diagram
Resources
Steering Committee
STAG
Development team
Summary of findings (GRADE) - RSV
Infant Efficacy/Effectiveness
RSV: Summary of Findings (GRADE)
Infant Efficacy/Effectiveness
Should RSVpreF vaccine vs. no RSVpreF vaccine be used in pregnant persons across different gestational age to prevent hospitalization in infants?
Should RSVpreF vaccine vs. no RSVpreF vaccine or placebo be used in pregnant persons at different time before delivery to prevent hospitalization in infants?
Should RSVpreF vaccine vs. no RSVpreF vaccine or placebo be used in pregnant persons to prevent hospitalization in infants?
Living Systematic Review
COVID 19
Chikungunya
Lassa Fever
Mpox
RSV
Effectiveness and immunogenicity outcome
Safety outcomes
Disease X
Resources
Steering Committee
STAG
Development team
Spotlights
Menu
Living Systematic Review
COVID 19
Chikungunya
Lassa Fever
Mpox
RSV
Effectiveness and immunogenicity outcome
Safety outcomes
Disease X
Resources
Steering Committee
STAG
Development team
Spotlights
Contact Us